Stay updated about the latest news on regulatory approvals and gain valuable insights into the intricate landscape of regulatory frameworks, guidelines, and processes that govern the development and commercialization of innovative therapies in the biotech sector!
News and Trends 20 Jul 2023
Endometrial cancer drug receives breakthrough therapy designation in China
HUTCHMED (China) Limited has announced that the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to the combination of fruquintinib and…